Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Total Revenue of $303.0 thousand for fiscal year 2025.
Cannabis Bioscience International Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $303.0K | +21.8% |
| 2024 | $248.8K | -21.5% |
| 2023 | $316.8K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $53.3K | -28.3% | +120.1% |
| August 31, 2025 | $24.2K | -86.5% | -67.4% |
| November 30, 2024 | $74.2K | +16.5% | -58.5% |
| August 31, 2024 | $178.9K | +145.7% | +391.3% |
| February 29, 2024 | $36.4K | -29.0% | -42.9% |
| November 30, 2023 | $63.7K | -22.8% | -12.5% |
| August 31, 2023 | $72.8K | — | +42.1% |
| February 28, 2023 | $51.3K | — | -37.9% |
- Cannabis Bioscience International Holdings, Inc. showed an increase of +21.8% in Total Revenue compared to the prior fiscal year.
- Over the 2023–2025 period, Cannabis Bioscience International Holdings, Inc.’s total revenue has declined by 4.4% (from $316.8 thousand to $303.0 thousand).
- The most recent figure is from Cannabis Bioscience International Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: